BOSTON (Legal Newsline) – A class action lawsuit filed in federal court this week alleges that a patent infringement lawsuit filed by multinational pharmaceutical company Novartis against generic ...

Lawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to deter competitors from creating generic alternatives to prescription drugs continue to grow. Teva ...

A fellow named Dennis Dilbeck has sued Netflix, based on his perception that two of the company's Patents were granted without full disclosure of prior art- and that lack of disclosure has provided ...

“To modernize our patent infrastructure, we need better tools to help inventors and examiners find relevant prior art.” Patent categories were established more than 100 years ago. There are dozens of ...

“Patents that have been thoroughly examined during prosecution are more likely to withstand validity challenges during IPR. To this end, it might be beneficial for practitioners to work closely with ...

"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific ...